Biofilm Investigation on Bearing Components of Explanted Hip Joint Prosthesis

Sponsor
Charite University, Berlin, Germany (Other)
Overall Status
Unknown status
CT.gov ID
NCT02853461
Collaborator
Ceram Tec GmbH (Other), Pro-Implant Foundation (Other)
200
1
33
6.1

Study Details

Study Description

Brief Summary

In this study the investigators sonicate the bearing components of the explanted hip prosthesis which allows highly sensitive detection of in vivo biofilms (qualitatively and quantitatively). The hip prosthesis bearing components are composed from different material. The purpose of this study is to analyse the resistance against biofilm adhesion of ceramic, metal and polyethylene prosthesis components through microbiologic analysis of sonicates.

Condition or Disease Intervention/Treatment Phase
  • Other: Sonication
  • Other: Microbiological analysis

Detailed Description

The main reasons for hip prosthesis failure are aseptic loosening and periprosthetic joint infection (PJI). The real frequency of PJI is probably largely underestimated because of non-standardized definition criteria, diagnostic procedure, treatment algorithm and other confounders. Therefore, data from joint registries are not reflecting the frequency of PJI and can be misleading; particularly low-grade PJI can be frequently misdiagnosed as aseptic failure.

Microbiological analysis of sonicate has in comparison with joint aspirate significantly higher sensitivity and specificity, which allows better detection of low grade infection. With aspiration only free-floating, high metabolically active, planktonic form of bacteria could be collected. Contrarily, the less metabolically active bacteria are hidden under the biofilm can remain undetected.

Sonication of prosthetic material mechanically dislodge the biofilm from surface and expose the sessile bacteria for the microbiological analysis.

All foreign materials provoke biofilm formation however, different materials showed different resistance for biofilm adhesion.

In this study patients with PJI are undergoing standard one- or two- stage revision procedure of the hip. The removed bearing components will be sonicated and sent in microbiological analysis. The ceramic, metal and polyethylene prosthesis components will undergo qualitative and quantitative microbiological analysis. The materials will be compared regarding to the presence of biofilm formation.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Biofilm Investigation on Ceramic, Metal and Polyethylene Bearing Components From Explanted Hip Joint Prosthesis
Study Start Date :
Jun 1, 2014
Anticipated Primary Completion Date :
Dec 1, 2016
Anticipated Study Completion Date :
Mar 1, 2017

Outcome Measures

Primary Outcome Measures

  1. Qualitative analysis of sonication fluid after sonication of explanted bearing components of the hip endoprosthesis during a revision surgery [Prospective: patient recruitment up to 2 years]

    Qualitative Analysis, i.e. frequency of positive sonication fluid cultures (No. positive/No. all cultures) deriving from 3 different biomaterials (namely: Ceramic, Cobalt-chrome-metal, and Polyethylene), the number of variables which will be evaluated following: bearing component and its material (Ceramic, Cobalt-chrome-metal, and Polyethylene). All three material types will be compared between each other regard to microbiology analysis of sonication fluid of bearing components.

  2. Quantitative Analysis e.g. No. of microorganisms in sonication fluid (CFU/ml) deriving from 3 different biomaterials (namely: Ceramic, Cobalt-chrome-metal, and Polyethylene). [Prospective: patient recruitment up to 2 years]

Secondary Outcome Measures

  1. Amount of patients with septic loosening of hip joint [Prospective: patient recruitment up to 2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subject must be aged 18 or more.

  • Subject must be scheduled to undergo an explanation of the hip endoprosthesis during the 1- or 2- stage revision procedure because of the septic or mechanical indication.

  • Subject must personally sign and date the informed consent document indicating that the subject has been informed of all pertinent aspects of the study.

Exclusion Criteria:
  • Patient not scheduled for the index Operation procedure with removal of hip endoprosthesis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Charité Universitätsmedizin Berlin Berlin Germany 10117

Sponsors and Collaborators

  • Charite University, Berlin, Germany
  • Ceram Tec GmbH
  • Pro-Implant Foundation

Investigators

  • Principal Investigator: Andrej Trampuz, MD, Charite University, Berlin, Germany

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Andrej Trampuz, MD, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT02853461
Other Study ID Numbers:
  • Endo 015/15
First Posted:
Aug 3, 2016
Last Update Posted:
Aug 4, 2016
Last Verified:
Aug 1, 2016
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Keywords provided by Andrej Trampuz, MD, Charite University, Berlin, Germany

Study Results

No Results Posted as of Aug 4, 2016